LinkedIn Profile

Access Sanarus Medical historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:sanarusmedical 43029 May 31st, 2019 12:00AM Sanarus Technologies 958 28.00 Open Medical Devices May 31st, 2019 03:33PM May 31st, 2019 03:33PM Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech Open Surgical Alternatives, Cryoablation, Breast Care, Breast Tumors, interventional radiology, radiology, diagnostic imaging, minimally invasive treatment Open 1249 Quarry Lane, Suite 150 Pleasanton California US 94566 Sanarus Medical Health Care Equipment & Services
private:sanarusmedical 43029 Mar 18th, 2018 12:00AM Sanarus Technologies 858 30.00 Open Medical Devices Mar 18th, 2018 04:05PM Mar 18th, 2018 04:05PM Open Sanarus Medical Health Care Equipment & Services
private:sanarusmedical 43029 Feb 17th, 2018 12:00AM Sanarus Technologies 834 32.00 Open Medical Devices Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech Sanarus Medical Health Care Equipment & Services
private:sanarusmedical 43029 Feb 16th, 2018 12:00AM Sanarus Technologies 834 32.00 Open Medical Devices Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech Sanarus Medical Health Care Equipment & Services
private:sanarusmedical 43029 Feb 15th, 2018 12:00AM Sanarus Technologies 834 32.00 Open Medical Devices Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech Sanarus Medical Health Care Equipment & Services
private:sanarusmedical 43029 Feb 14th, 2018 12:00AM Sanarus Technologies 834 32.00 Open Medical Devices Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech Sanarus Medical Health Care Equipment & Services
private:sanarusmedical 43029 Feb 13th, 2018 12:00AM Sanarus Technologies 834 32.00 Open Medical Devices Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech Sanarus Medical Health Care Equipment & Services
private:sanarusmedical 43029 Feb 12th, 2018 12:00AM Sanarus Technologies 834 32.00 Open Medical Devices Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech Sanarus Medical Health Care Equipment & Services
private:sanarusmedical 43029 Feb 11th, 2018 12:00AM Sanarus Technologies 834 32.00 Open Medical Devices Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech Sanarus Medical Health Care Equipment & Services
private:sanarusmedical 43029 Feb 10th, 2018 12:00AM Sanarus Technologies 834 32.00 Open Medical Devices Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech Sanarus Medical Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.